-
公开(公告)号:US20180244606A1
公开(公告)日:2018-08-30
申请号:US15758709
申请日:2016-09-16
申请人: Metacrine, Inc.
IPC分类号: C07C233/54 , A61K45/06 , A61K31/216 , C07C271/28 , A61K31/27 , C07C255/57 , A61K31/277 , C07D309/08 , A61K31/351 , A61K31/337 , C07D305/08 , C07D335/02 , A61K31/382 , C07D205/04 , A61K31/397 , C07D265/30 , A61K31/5375 , C07C323/50 , C07C317/44 , C07D211/94 , A61K31/45 , C07C235/04 , C07C235/40 , C07D211/06 , A61K31/4453 , C07C235/82 , C07D231/12 , A61K31/415 , C07D213/40 , A61K31/4406 , C07D261/08 , A61K31/42 , C07D295/135 , A61K31/402 , C07D231/56 , A61K31/416 , A61K31/404 , C07D209/04 , C07D317/58 , A61K31/36 , C07D295/26 , C07D295/195 , C07D277/28 , A61K31/426 , A61K31/4184 , C07D235/08 , C07D249/18 , A61K31/4192 , C07D239/42 , A61K31/505 , C07D241/20 , A61K31/4965 , C07D237/20 , A61K31/50 , A61P1/16
CPC分类号: C07C233/54 , A61K31/16 , A61K31/216 , A61K31/27 , A61K31/277 , A61K31/337 , A61K31/351 , A61K31/36 , A61K31/382 , A61K31/397 , A61K31/402 , A61K31/404 , A61K31/415 , A61K31/416 , A61K31/4184 , A61K31/4192 , A61K31/42 , A61K31/426 , A61K31/4406 , A61K31/4453 , A61K31/45 , A61K31/4965 , A61K31/50 , A61K31/505 , A61K31/5375 , A61K45/06 , A61P1/16 , C07C233/63 , C07C233/65 , C07C233/81 , C07C233/87 , C07C235/04 , C07C235/16 , C07C235/40 , C07C235/56 , C07C235/64 , C07C235/82 , C07C237/24 , C07C255/57 , C07C255/60 , C07C271/24 , C07C271/28 , C07C311/07 , C07C311/08 , C07C317/32 , C07C317/44 , C07C323/50 , C07C323/61 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/16 , C07C2602/42 , C07C2603/74 , C07D205/04 , C07D209/04 , C07D211/06 , C07D211/62 , C07D211/76 , C07D211/94 , C07D211/96 , C07D213/40 , C07D231/12 , C07D231/56 , C07D235/04 , C07D235/08 , C07D237/20 , C07D239/42 , C07D241/20 , C07D249/18 , C07D261/08 , C07D265/30 , C07D277/28 , C07D295/088 , C07D295/135 , C07D295/195 , C07D295/26 , C07D305/08 , C07D309/08 , C07D317/58 , C07D319/12 , C07D335/02 , A61K2300/00
摘要: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
-
公开(公告)号:US10039844B2
公开(公告)日:2018-08-07
申请号:US14956431
申请日:2015-12-02
IPC分类号: A61K51/00 , A61M36/14 , A61K51/04 , C07D295/26 , G01N33/574 , G01N33/60
摘要: A novel pyruvate kinase M2 (PKM2)-specific activator, [11C]DASA-23 and derivatives thereof, and methods for their rapid synthesis are provided. The probes are particularly useful in methods for the non-invasive positron emission tomography (PET) detection and imaging of PKM2 expression in subcutaneous and orthotopic tumors. [11C]DASA-23 cell uptake correlates with PKM2 protein expression in cultured tumor cells and orthotopic tumors are delineated from the surrounding normal brain tissue in vivo.
-
公开(公告)号:US09994537B2
公开(公告)日:2018-06-12
申请号:US15672165
申请日:2017-08-08
IPC分类号: C07D295/205 , C07D207/08 , C07D471/10 , C07D417/04 , C07D403/04 , C07D401/04 , C07D295/26 , C07D265/30 , C07D207/12 , C07D211/38 , C07D211/58 , C07D207/14 , C07D211/14 , C07D498/08 , C07D211/62 , C07D487/04 , C07D207/16
CPC分类号: C07D295/205 , C07D207/08 , C07D207/12 , C07D207/14 , C07D207/16 , C07D211/14 , C07D211/38 , C07D211/58 , C07D211/62 , C07D265/30 , C07D295/26 , C07D401/04 , C07D403/04 , C07D417/04 , C07D471/10 , C07D487/04 , C07D498/08
摘要: Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
-
公开(公告)号:US09975864B2
公开(公告)日:2018-05-22
申请号:US15100361
申请日:2014-12-02
IPC分类号: C07D295/26 , C07D203/24 , C07D417/12
CPC分类号: C07D295/26 , C07B2200/13 , C07D203/24 , C07D417/12
摘要: The present disclosure provides crystalline piperidine sulfamoyl intermediates of formula 8 and 9. The present disclosure also relates to an improved process for the preparation of cobicistat using compounds of formulae 8 and 9.
-
公开(公告)号:US20180043040A1
公开(公告)日:2018-02-15
申请号:US15674701
申请日:2017-08-11
发明人: Corinne Gaye Beinat , Israt Shamima Alam , Michelle L. James , Sanjiv S. Gambhir , Ananth Srinivasan
IPC分类号: A61K51/04 , C07B59/00 , C07D295/26
摘要: The present disclosure provides a positron emission tomography (PET)-detectable 1-((2-fluoro-6-[18F]fluorophenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine ([18F]DASA-23) probe that can selectively bind to the pyruvate kinase variant M2 (PKM2) found in cancer cells, such as of human glioma. Given the importance of PKM2 in the regulation of tumor metabolism, there is an on-going need to non-invasively measure its expression through the development of PKM2-specific radiopharmaceuticals. Precursors useful for the synthesis of the radiolabeled [18F]DASA-23-PKM2-specific probe and related compounds, and their methods of synthesis, are provided. Since the half-life of the 18F isotope is approximately 110 min, it is advantageous for a practitioner to attach the radionuclide to the precursor shortly before administration. Therefore, a precursor compound suitable for receiving the radionuclide and capable of specifically binding to the PKM2 variant can be provided.
-
公开(公告)号:US20170320818A1
公开(公告)日:2017-11-09
申请号:US15656769
申请日:2017-07-21
发明人: JU-TAO GUO , XIAODONG XU , TIMOTHY M. BLOCK
IPC分类号: C07C311/46 , A61K31/167 , C07D295/26 , C07D281/16 , C07D223/04 , C07D213/40 , C07D211/96 , C07D307/52 , A61K31/18 , A61K31/341 , A61K31/4406 , A61K31/4453 , A61K31/553 , A61K31/55 , A61K31/54 , A61K31/5375 , C07D307/68 , A61K31/44 , A61K31/541 , A61K31/445 , A61K31/5377
摘要: The present invention provides sulfamoylbenzamide derivatives, and pharmaceutical compositions thereof. In certain embodiments, the compounds and pharmaceutical compositions of the invention inhibit pregenomic RNA encapsidation. In other embodiments, the compounds and pharmaceutical compositions of the invention are useful for treating Hepatitis B virus (HBV) infection.
-
公开(公告)号:US20170233354A1
公开(公告)日:2017-08-17
申请号:US15500174
申请日:2015-07-30
申请人: INSERM (INSTITUT NATIONAL DE SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE DE MONTPELLIER , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , UNIVERSITÉ DE STRASBOURG
IPC分类号: C07D295/26 , C07D249/08 , C07D233/64 , A61K31/18 , C07D257/04 , C07C311/20 , A61K31/4453 , A61K31/454 , C07D209/08 , C07D235/04
CPC分类号: C07D295/26 , A61K31/18 , A61K31/4453 , A61K31/454 , C07C311/20 , C07D209/08 , C07D233/64 , C07D235/04 , C07D235/18 , C07D249/08 , C07D257/04 , C07D263/57
摘要: The invention pertains to novel FLT3 receptor antagonists of general formula (1). The compounds are useful for the treatment or the prevention of pain disorders, cancer and autoimmune diseases.
-
公开(公告)号:US09707230B2
公开(公告)日:2017-07-18
申请号:US15076258
申请日:2016-03-21
发明人: Craig J. Thomas , Douglas S. Auld , James Inglese , Amanda P. Skoumbourdis , Jian-Kang Jiang , Matthew B. Boxer
IPC分类号: A61K31/496 , C07D495/14 , A61K31/5025 , A61K31/445 , A61K31/495 , C07D295/26 , C07D319/18
CPC分类号: A61K31/496 , A61K31/445 , A61K31/495 , A61K31/5025 , C07D295/26 , C07D319/18 , C07D495/14
摘要: Disclosed are pyruvate kinase M2 activators, which are, bis sulfonamide piperazinyl compounds of Formula (I) and 2,4-disubstituted 4H-thieno[3,2-b]pyrrole-2-(substituted benzyl)pyridazin-3(2H)ones of Formula (II), wherein L and R1 to R16 are as defined herein, that are useful in treating a number of diseases that are treatable by the activation of PKM2, for example, cancer and anemia,
-
公开(公告)号:US09689841B2
公开(公告)日:2017-06-27
申请号:US14241358
申请日:2012-08-27
申请人: Gyula Vigh , Ming-Chien Li
发明人: Gyula Vigh , Ming-Chien Li
IPC分类号: C07C311/32 , G01N27/447 , C09K11/06 , C07C311/42 , C07D233/64 , C07D295/088 , C07D295/13 , C07D295/26 , C07C311/37 , G01N33/58
CPC分类号: G01N27/44795 , C07C311/32 , C07C311/37 , C07C311/42 , C07C2603/50 , C07D233/64 , C07D295/088 , C07D295/13 , C07D295/26 , C09K11/06 , C09K2211/1007 , C09K2211/1011 , C09K2211/1033 , C09K2211/1044 , G01N27/447 , G01N33/582 , Y10T436/143333
摘要: UV-Absorbing and fluorescent pl markers for isoelectric focusing separations and fluorescent labeling, and methods for making and using the markers.
-
公开(公告)号:US20170166542A1
公开(公告)日:2017-06-15
申请号:US15372778
申请日:2016-12-08
发明人: Niklas von Wolff , Joëlle Char , Thibault Cantat
IPC分类号: C07D295/26 , C07C315/04 , C07D213/71
CPC分类号: C07D295/26 , C07C315/04 , C07D213/71 , C07D265/30 , C07C317/14 , C07C317/22
摘要: A one pot single step process is described for the synthesis of a compound, including a labeled compound, containing a sulfonyl functional group comprising the step of mixing together a silane, an SO2 source, an electrophilic compound, an activating compound and optionally a metal catalyst. A process for producing tracers from a labeled sulfonyl containing compound prepared by the described process is also included.
-
-
-
-
-
-
-
-
-